ArticleBMC musculoskeletal disorders2025
Comparison of orthofix external fixator combined with vascularized fibula graft versus single segmental femoral lengthening for treating femoral defects ≥ 6 cm: a retrospective study.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundBone lengthening and free vascularized fibula graft (FVFG) represent two prevalent modalities for bone defect repair. The objective of this study was to compare the efficacy disparities between FVFG and single - segmental bone lengthening (BL) when the Orthofix external fixator was utilized in the treatment process.
methodsThe follow - up data of 72 patients with femoral defects, who received treatment from January 2009 to May 2019, were collected for retrospective analysis. Among them, 60 comparable patients were stratified into two groups: one group of 30 patients received free vascularized fibular graft in combination with Orthofix external fixation (FVFG group), and the other group of 30 patients underwent single - segmental bone lengthening using the Orthofix external fixator (BL group). The specific aspects evaluated encompassed operation time, intraoperative blood loss, postoperative Activities of Daily Living (ADL) score, assessment by the Association for the Study and Application of the Method of Ilizarov (ASAMI), limb length discrepancy (LLD), external fixation index, bone union status, and complications.
results1.Surgical - related indicators: The mean operation time in the FVFG group ( 5.04 ± 1.22 h) was significantly longer than that in the BL group (1.58 ± 0.56 h, p<0.001). The intraoperative blood loss (450 ± 190.73 ml) in the FVFG group was substantially higher than that in the BL group (120 ± 46.23 ml, p<0.01). Although the duration of external fixator use in the FVFG group (16.9 ± 3.52 months) was marginally longer than that in the BL group (15.53 ± 2.09 months), this difference did not reach statistical significance (p=0.073). 2.Postoperative complications: According to the Paley classification system, no significant differences were observed between the two groups in terms of nail infection, nail loosening, limb edema, nonunion (including nonunion in the BL group and fibula nonunion in the FVFG group), and postoperative fractures. All complications were effectively managed through appropriate treatment strategies. 3.Functional evaluation: Based on the ASAMI criteria, the excellent - to - good rate of bone outcomes in the FVFG group was 80.0%, while the BL group demonstrated superior results (p = 0.028). The excellent - to - good rate of limb function in the FVFG group was 36.6%, and there was no significant difference between the two groups (p = 0.537).
conclusionFor the treatment of femoral defects measuring ≥ 6 cm, single - segmental bone lengthening with the Orthofix external fixator exhibited advantages in terms of shorter operation time and reduced blood loss compared to FVFG combined with the Orthofix external fixator. Although other outcomes were comparable between the two groups, FVFG demonstrated broader applicability across diverse bone defect classifications, primarily constrained by the defect length and the vascular condition of the recipient site.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.